{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:41:10Z","timestamp":1794757270275,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404059"],"award-info":[{"award-number":["82404059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8240101442"],"award-info":[{"award-number":["8240101442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pleural spread or recurrence of thymic epithelial tumors (TETs) is a tricky puzzle in the clinic and there is currently no recognized effective treatment. This trial evaluated the safety and efficacy of cytoreductive surgery and hyperthermic intrathoracic chemotherapy (S-HITOC) for TETs with pleural spread or recurrence. Here, we reported short-term outcomes of enrolled 45 patients receiving S-HITOC with 25\u2009mg\/m<jats:sup>2<\/jats:sup> doxorubicin and 50\u2009mg\/m<jats:sup>2<\/jats:sup> cisplatin. The pleural tumor index (PTI) has been proposed for evaluating pleural tumor burden. Treatment-related adverse events of grade \u22653 occurred in eight (17.8%) patients. The pain Visual analog scale (VAS) score was 5.4\u2009\u00b1\u20091.9 on the 1st day after treatment and was similar to that at baseline level on the 7th day after treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.218). There was no significant difference in the quality of life score (<jats:italic>p<\/jats:italic>\u2009=\u20090.676) between baseline and the 60th day after treatment. The estimated 2-year PFS and OS rates were 82.8% and 100.0%, respectively. Subgroup analyses revealed that patients with PTI scores &gt;10 had worse PFS than those with PTI scores \u226410 (p\u2009&lt;\u20090.001). S-HITOC had a manageable complication rate. Early clinical outcomes confirmed that S-HITOC offers encouraging oncological benefits for TETs and satisfactory control of myasthenia gravis. Trial number: NCT05446935.<\/jats:p>","DOI":"10.1038\/s41467-025-60386-0","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:02:12Z","timestamp":1749038532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cytoreductive surgery and hyperthermic intrathoracic chemotherapy in thymic epithelial tumors with pleural spread or recurrence: a prospective, single-arm, phase II study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-9024","authenticated-orcid":false,"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-667X","authenticated-orcid":false,"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-8843","authenticated-orcid":false,"given":"Jiahao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4184-7844","authenticated-orcid":false,"given":"Fei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-0161","authenticated-orcid":false,"given":"Yongqiang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-7290","authenticated-orcid":false,"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-3141","authenticated-orcid":false,"given":"Jianyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"60386_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jtho.2023.09.1447","volume":"19","author":"W Fang","year":"2024","unstructured":"Fang, W. et al. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors. J. Thorac. Oncol. 19, 52\u201370 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"60386_CR2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/JTO.0000000000000370","volume":"9","author":"A Sandri","year":"2014","unstructured":"Sandri, A. et al. Long-term results after treatment for recurrent thymoma: a multicenter analysis. J. Thorac. Oncol. 9, 1796\u20131804 (2014).","journal-title":"J. Thorac. Oncol."},{"key":"60386_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.athoracsur.2006.05.028","volume":"82","author":"CD Wright","year":"2006","unstructured":"Wright, C. D. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann. Thorac. Surg. 82, 1234\u20131239 (2006).","journal-title":"Ann. Thorac. Surg."},{"key":"60386_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.jtcvs.2007.07.049","volume":"134","author":"J Huang","year":"2007","unstructured":"Huang, J. et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J. Thorac. Cardiovasc Surg. 134, 1477\u20131483 (2007).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"60386_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.791647","volume":"11","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Induction therapy followed by surgery for unresectable thymic epithelial tumours. Front Oncol. 11, 791647 (2022).","journal-title":"Front Oncol."},{"key":"60386_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704220","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Induction strategy for locally advanced thymoma. Front Oncol. 11, 704220 (2021).","journal-title":"Front Oncol."},{"key":"60386_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0039-1700883","volume":"69","author":"T Markowiak","year":"2021","unstructured":"Markowiak, T. et al. Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination. Thorac. Cardiovasc. Surg. 69, 157\u2013164 (2021).","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"60386_CR8","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.3390\/cancers13184580","volume":"13","author":"M Ried","year":"2021","unstructured":"Ried, M. et al. Hyperthermic intrathoracic chemotherapy (HITOC) after cytoreductive surgery for pleural malignancies\u2014a retrospective, multicentre study. Cancers (Basel). 13, 4580 (2021).","journal-title":"Cancers (Basel)."},{"key":"60386_CR9","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.3390\/cancers14205035","volume":"14","author":"B Chappuy","year":"2022","unstructured":"Chappuy, B. et al. Subtotal pleurectomy with intrathoracic chemo hyperthermia (HITHOC) for IVa thymomas: de novo versus recurrent pleural disease. Cancers (Basel). 14, 5035 (2022).","journal-title":"Cancers (Basel)."},{"key":"60386_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/icvts\/ivaa019","volume":"30","author":"V Aprile","year":"2020","unstructured":"Aprile, V. et al. Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?. Interact. Cardiovasc-. Thorac. Surg. 30, 765\u2013772 (2020).","journal-title":"Interact. Cardiovasc-. Thorac. Surg."},{"key":"60386_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1510\/icvts.2010.264036","volume":"13","author":"M Yano","year":"2011","unstructured":"Yano, M. et al. Number of recurrent lesions is a prognostic factor in recurrent thymoma. Interact. Cardiovasc. Thorac. Surg. 13, 21\u201324 (2011).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"60386_CR12","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.athoracsur.2014.01.042","volume":"97","author":"K Okuda","year":"2014","unstructured":"Okuda, K. et al. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan. Ann. Thorac. Surg. 97, 1743\u20131748 (2014).","journal-title":"Ann. Thorac. Surg."},{"key":"60386_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.athoracsur.2009.05.019","volume":"88","author":"Y Ishikawa","year":"2009","unstructured":"Ishikawa, Y. et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann. Thorac. Surg. 88, 952\u2013957 (2009).","journal-title":"Ann. Thorac. Surg."},{"key":"60386_CR14","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.ejcts.2010.12.064","volume":"39","author":"D Fabre","year":"2011","unstructured":"Fabre, D. et al. Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma. Eur. J. Cardiothorac. Surg. 39, e133\u2013e138 (2011).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"60386_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.athoracsur.2012.05.102","volume":"94","author":"NM Mollberg","year":"2012","unstructured":"Mollberg, N. M. et al. Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann. Thorac. Surg. 94, 1086\u20131092 (2012).","journal-title":"Ann. Thorac. Surg."},{"key":"60386_CR16","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.athoracsur.2015.04.151","volume":"100","author":"T Williams","year":"2015","unstructured":"Williams, T. et al. Extended pleurectomy and decortication for malignant pleural mesothelioma is an effective and safe cytoreductive surgery in the elderly. Ann. Thorac. Surg. 100, 1868\u20131874 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"60386_CR17","doi-asserted-by":"crossref","unstructured":"de Bree, E. et al. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 121, 480\u2212487 (2002).","DOI":"10.1378\/chest.121.2.480"},{"key":"60386_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtcvs.2012.10.013","volume":"145","author":"A Yellin","year":"2013","unstructured":"Yellin, A. et al. Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience. J. Thorac. Cardiovasc. Surg. 145, 83\u201387 (2013). discussion 87-89.","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"60386_CR19","doi-asserted-by":"publisher","first-page":"e041511","DOI":"10.1136\/bmjopen-2020-041511","volume":"10","author":"T Markowiak","year":"2020","unstructured":"Markowiak, T. et al. Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany. BMJ Open10, e041511 (2020).","journal-title":"BMJ Open"},{"key":"60386_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ejcts\/ezv039","volume":"49","author":"MC Ambrogi","year":"2016","unstructured":"Ambrogi, M. C. et al. Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy. Eur. J. Cardiothorac. Surg. 49, 321\u2013326 (2016).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"60386_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.21037\/atm-20-6307","volume":"9","author":"C Larisch","year":"2021","unstructured":"Larisch, C. et al. Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure. Ann. Transl. Med. 9, 953 (2021).","journal-title":"Ann. Transl. Med."},{"key":"60386_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","volume":"138","author":"TR Tilleman","year":"2009","unstructured":"Tilleman, T. R. et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J. Thorac. Cardiovasc. Surg. 138, 405\u2013411 (2009).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"60386_CR23","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","volume":"24","author":"WG Richards","year":"2006","unstructured":"Richards, W. G. et al. Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J. Clin. Oncol. 24, 1561\u20131567 (2006).","journal-title":"J. Clin. Oncol."},{"key":"60386_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11748-015-0535-x","volume":"63","author":"H Ishibashi","year":"2015","unstructured":"Ishibashi, H. et al. Interim results of pleurectomy\/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy. Gen. Thorac. Cardiovasc. Surg. 63, 395\u2013400 (2015).","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"60386_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1245\/s10434-022-12461-9","volume":"30","author":"T Vandaele","year":"2023","unstructured":"Vandaele, T. et al. Hyperthermic intrathoracic chemotherapy (HITHOC) for pleural disseminated thymoma: a systematic literature review. Ann. Surg. Oncol. 30, 543\u2013560 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"60386_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/ejcts\/ezu217","volume":"47","author":"M Ried","year":"2015","unstructured":"Ried, M. et al. Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure. Eur. J. Cardiothorac. Surg. 47, 563\u2013566 (2015).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"60386_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jtcvs.2012.10.042","volume":"145","author":"RB Cameron","year":"2013","unstructured":"Cameron, R. B. et al. Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation. J. Thorac. Cardiovasc Surg. 145, 496\u2013504 (2013).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"60386_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2017.02.014","volume":"108","author":"JM Maury","year":"2017","unstructured":"Maury, J. M. et al. Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymoma. Lung Cancer 108, 1\u20136 (2017).","journal-title":"Lung Cancer"},{"key":"60386_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.21037\/jtd-23-759","volume":"16","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy for the treatment of thymic epithelial malignancies with pleural spread or recurrence (CHOICE): a study protocol for a prospective, open, single-arm study. J. Thorac. Dis. 16, 760\u2013767 (2024).","journal-title":"J. Thorac. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60386-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:02:14Z","timestamp":1749038534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60386-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60386"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60386-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5175"}}